These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
101 related articles for article (PubMed ID: 6749181)
21. The formation of surface membrane vesicles from schistosomula of Schistosoma mansoni. Kusel JR; Gazzinelli G; Colley DG; de Souza CP; Cordeiro MN Parasitology; 1984 Dec; 89 ( Pt 3)():483-94. PubMed ID: 6514380 [TBL] [Abstract][Full Text] [Related]
22. Studies of the antibody-dependent killing of schistosomula of Schistosoma mansoni employing haptenic target antigens. I. Evidence that the loss in susceptibility to immune damage undergone by developing schistosomula involves a change unrelated to the masking of parasite antigens by host molecules. Moser G; Wassom DL; Sher A J Exp Med; 1980 Jul; 152(1):41-53. PubMed ID: 7400756 [TBL] [Abstract][Full Text] [Related]
23. Monoclonal antibodies against surface antigens of schistosomula of Schistosoma mansoni. Taylor DW; Butterworth AE Parasitology; 1982 Feb; 84(1):65-82. PubMed ID: 7063255 [TBL] [Abstract][Full Text] [Related]
24. Protection by phospholipids of Schistosoma mansoni schistosomula against the action of cytotoxic antibodies and complement. Billecocq A Mol Biochem Parasitol; 1987 Sep; 25(2):133-42. PubMed ID: 3313040 [TBL] [Abstract][Full Text] [Related]
25. Surface antigens of Schistosoma mansoni. Taylor DW; Hayunga EG; Vannier WE Mol Biochem Parasitol; 1981 Jul; 3(3):157-68. PubMed ID: 7254250 [No Abstract] [Full Text] [Related]
26. Identification by monoclonal antibody of a major (28 kDa) surface membrane antigen of Schistosoma mansoni. Harn DA; Mitsuyama M; Huguenel ED; Oligino L; David JR Mol Biochem Parasitol; 1985 Sep; 16(3):345-54. PubMed ID: 4058486 [TBL] [Abstract][Full Text] [Related]
27. Schistosoma mansoni: loss of the ability of schistosomula to bind mouse complement following intravenous injection into mice. Ruppel A; Rother U; Diesfeld HJ Tropenmed Parasitol; 1984 Mar; 35(1):23-8. PubMed ID: 6369693 [TBL] [Abstract][Full Text] [Related]
28. Protein synthesis and release by cultured schistosomula of Schistosoma mansoni. Harrop R; Wilson RA Parasitology; 1993 Sep; 107 ( Pt 3)():265-74. PubMed ID: 8233590 [TBL] [Abstract][Full Text] [Related]
29. Interactions between human eosinophils and schistosomula of Schistosoma mansoni. II. The mechanism of irreversible eosinophil adherence. Butterworth AE; Vadas MA; Wassom DL; Dessein A; Hogan M; Sherry B; Gleich GJ; David JR J Exp Med; 1979 Dec; 150(6):1456-71. PubMed ID: 390086 [TBL] [Abstract][Full Text] [Related]
30. Epitopes expressed on very low Mr Schistosoma mansoni adult tegumental antigens conform to a general pattern of life-cycle cross-reactivity. Simpson AJ; Hagan P; Hackett F; Omer Ali P; Smithers SR Parasitology; 1990 Feb; 100 Pt 1():73-81. PubMed ID: 1690382 [TBL] [Abstract][Full Text] [Related]
31. Schistosoma mansoni: human serum and release of proteins from schistosomula. Campana-Pereira MA; Rumjanek FD Exp Parasitol; 1987 Dec; 64(3):267-74. PubMed ID: 3119363 [TBL] [Abstract][Full Text] [Related]
32. The effect of age on the susceptibility of schistosomula of Schistosoma mansoni to damage by human eosinophils and neutrophils, in vitro. MacDonald AJ; Moqbel R; Kay AB J Parasitol; 1985 Dec; 71(6):838-40. PubMed ID: 4093819 [No Abstract] [Full Text] [Related]
33. Schistosoma mansoni: evidence for a role of serum factors in protecting artificially transformed schistosomula against antibody-mediated killing in vitro. Tavares CA; Soares RC; Coelho PM; Gazzinelli G Parasitology; 1978 Oct; 77(2):225-43. PubMed ID: 704150 [TBL] [Abstract][Full Text] [Related]
34. Ultrastructural observations on the in vitro interaction of rat neutrophils with schistosomula of Schistosoma mansoni in the presence of antibody and/or complement. Incani RN; McLaren DJ Parasitology; 1983 Apr; 86 (Pt 2)():345-57. PubMed ID: 6856337 [TBL] [Abstract][Full Text] [Related]
35. Studies on phospholipid turnover argue against sloughing of tegumental membranes in adult Schistosoma mansoni. Brouwers JF; Skelly PJ; Van Golde LM; Tielens AG Parasitology; 1999 Sep; 119 ( Pt 3)():287-94. PubMed ID: 10503254 [TBL] [Abstract][Full Text] [Related]
36. A quantitative proteomic analysis of the tegumental proteins from Schistosoma mansoni schistosomula reveals novel potential therapeutic targets. Sotillo J; Pearson M; Becker L; Mulvenna J; Loukas A Int J Parasitol; 2015 Jul; 45(8):505-16. PubMed ID: 25910674 [TBL] [Abstract][Full Text] [Related]
37. Mapping of the complement C9 binding domain in paramyosin of the blood fluke Schistosoma mansoni. Deng J; Gold D; LoVerde PT; Fishelson Z Int J Parasitol; 2007 Jan; 37(1):67-75. PubMed ID: 17123534 [TBL] [Abstract][Full Text] [Related]
38. Human antibody responses to Schistosoma mansoni: the influence of epitopes shared between different life-cycle stages on the response to the schistosomulum. Dunne DW; Grabowska AM; Fulford AJ; Butterworth AE; Sturrock RF; Koech D; Ouma JH Eur J Immunol; 1988 Jan; 18(1):123-31. PubMed ID: 2450028 [TBL] [Abstract][Full Text] [Related]
39. Mechanisms of evasion of Schistosoma mansoni schistosomula to the lethal activity of complement. Ramalho-Pinto FJ; Carvalho EM; Horta MF Mem Inst Oswaldo Cruz; 1992; 87 Suppl 4():111-6. PubMed ID: 1285336 [TBL] [Abstract][Full Text] [Related]
40. Monoclonal antibodies demonstrate similarity of surface antigens on different clones of Schistosoma mansoni schistosomula. Smith MA; Clegg JA; Snary D Trans R Soc Trop Med Hyg; 1984; 78(2):187-9. PubMed ID: 6380013 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]